Obesity Clinical Trial
— CHATOfficial title:
Piloting Visual Chat in Internet Obesity Treatment
NCT number | NCT03491293 |
Other study ID # | 18-0409 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 6, 2018 |
Est. completion date | November 30, 2018 |
Verified date | December 2018 |
Source | University of Vermont |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
CHAT is an internet-based weight loss research program designed for women with overweight or obesity who want to lose weight through dietary change and increased physical activity. Participants will be randomized into a group-based online program who meet via a text chat or a video chat.
Status | Completed |
Enrollment | 32 |
Est. completion date | November 30, 2018 |
Est. primary completion date | November 30, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years old - BMI between 25 and 55 - Free of medical problems that would preclude participation in a behavioral weight reduction program containing an exercise component - Not currently pregnant or pregnant in the previous 6 months or breastfeeding - Must have a computer at home or work with access to the Internet - Only one member of a household is eligible to participate - Must successfully complete a self-monitoring diary of foods consumed for 3 days - must be willing to share access to self monitoring information collected via My Fitness Pal by friending the CHAT research team - Not currently on medication that might affect weight loss - Not enrolled in another weight loss program Exclusion Criteria: - BMI less than 25 or more than 55 - Lost 10 pounds or more in the last 6 months - Had a heart attack or stroke in the past 6 months - Ever had weight loss surgery - Currently taking medications for weight loss - Persons required by their doctor to follow a special diet (other than low fat) - Plans to move from the area in the upcoming 9 months - Schedules that make it likely someone would have difficulty attending the scheduled chat groups |
Country | Name | City | State |
---|---|---|---|
United States | Behavioral Weight Management Program/Univ of Vermont | Burlington | Vermont |
United States | University of South Carolina | Columbia | South Carolina |
Lead Sponsor | Collaborator |
---|---|
University of Vermont | University of South Carolina, University of Tennessee |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight loss from baseline | The investigators will assess weight change differences between subjects randomized to receive an internet program alone with text chat vs. an internet program with visual chat and bodytrace smart scales. Weight will be assessed at baseline, 2 months after intervention begins, and at the end of intervention using a calibrated digital scale (Tanita, WB800S) with subjects in street clothes, without shoes. | baseline, 2 months, 6 months | |
Secondary | Attendance at chat | The group facilitator will record attendance at chats. Attendance at chat will be compared by treatment arm. Rate of attendance is calculated as number of meetings attended out of a total possible 24 meetings over the course of the study. | 6 months | |
Secondary | Self monitoring dietary intake | Number of weekly journals submitted out of a possible 24 weeks total will give the investigators the rate of self monitoring. Rates of self monitoring will be compared by treatment arm. | 6 months | |
Secondary | Self monitoring weight | Number of daily weights submitted over the course of 24 weeks divided by the possible total of weights will give the rate of weight self-monitoring (7/week x 24 weeks = 168 possible weights). The VIDEO arm will be provided with BodyTrace electronic scales that report weight to a secure database via cellular connectivity. Subjects in the TEXT arm will report their weights to their facilitator using their own digital scale at home. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |